Dr. Koliani-Pace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
326 Washington Street
Norwich, CT 06360Phone+1 860-889-8331
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Gastroenterology, 2015 - 2018
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2012 - 2015
Uconn School Of MedicineClass of 2012
Certifications & Licensure
CT State Medical License 2019 - 2025
NH State Medical License 2018 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 31 citationsComparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Dana J. Lukin, David Faleck, Ronghui Xu, Yiran Zhang, A Weiss
Clinical Gastroenterology and Hepatology. 2020-10-08 - 23 citationsSystematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event...Eric D. Shah, Elliot Coburn, Anil Nayyar, Kerry Jo Lee, Jenna L. Koliani-Pace
Alimentary Pharmacology & Therapeutics. 2020-03-01 - 44 citationsDevelopment and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam Winters
Clinical Gastroenterology and Hepatology. 2020-02-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
